Protection of Exogenous Phosphocreatine for Myocardium in Percutaneous Coronary Intervention Related to Inflammation

CONCLUSIONS: Exogenous phosphocreatine reduces stent implantation, triggers inflammation manifested as decreased serum levels of IL-6 and the aggregation of neutrophils, and protects the myocardium of the patients undergoing PCI. These findings provided the potential mechanism and treatment for myocardial injury associated with PCI.PMID:35345256 | DOI:10.31083/j.rcm2303089

Source: Reviews in Cardiovascular Medicine - March 29, 2022 Category: Cardiology Authors: Ming-Ying Ling Yi-Ping Song Chun Liu Zhi-Hao Wang Yan Wang Xue-Hui Li Zhen Zhang Rong-Xiang Zhou Liang-Yi Qie Man Li Yun-Ling Xiao Huan-Qin Chen Yan-Qiu Xing Source Type: research